Abstract
THE MDM2 proto-oncogene is found amplified in a variety of tumours1. The oncogenic capacity of the MDM2 protein is attributed to its ability to bind the p53 tumour-suppressor protein and mask its transcriptional activation potential2,3. Here we show that MDM2 makes a functional contact with two cooperating transcription factors, E2F1 and DPI (refs 4, 5), which are involved in S-phase progression6. MDM2 contacts the activation domain of E2F1 using residues conserved in the activation domain of p53. However, in contrast to its repression of p53 activity, MDM2 stimulates the activation capacity of E2F1/DP1. These results indicate that MDM2 not only releases a proliferative block by silencing the tumour suppressor p53, it also positively augments proliferation by stimulating the S-phase inducing transcription factors E2F1/DPI.
Similar content being viewed by others
References
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L. & Vogelstein, B. Nature 358, 80–83 (1992).
Oliner, J. D. et al. Nature 362, 857–860 (1993).
Momand, J., Zambetti, G. P., Olson, D. C., George, D. & Levine, A. J. Cell 69, 1237–1245 (1992).
Bandara, R. L., Buck, V. M., Zamanian, M., Johnston, L. H. & La Thangue, N. B. EMBO J. 12, 4317–4324 (1993).
Helin, K. et al. Genes Dev. 7, 1850–1861 (1993).
Johnson, D. G., Schwarz, J. K., Cress, W. D. & Nevins, J. R. Nature 365, 349–352 (1993).
Brown, D. R., Deb, S., Munoz, M. B., Subler, M. A. & Deb, S. P. Molec. cell. Biol. 13, 6849–6857 (1993).
Haines, D. S., Landers, J. E., Engle, L. J. & George, D. L. Molec. cell. Biol. 14, 1171–1178 (1994).
Picksley, S. M., Vojtesek, B., Sparks, A. & Lane, D. P. Oncogene 9, 2523–2529 (1994).
Hagemeier, C., Cook, A. & Kouzarides, T. Nucleic Acids Res. 21, 4998–5004 (1993).
Seto, E. et al. Proc. natn. Acad. Sci. U.S.A. 89, 12028–12032 (1992).
Helin, K., Harlow, E. & Fattay, A. Molec. cell. Biol. 13, 6501–6508 (1993).
Flemington, E. K., Spek, S. H. & Kaelin, W. G. Proc. natn. Acad. Sci. U.S.A. 90, 6914–6918 (1993).
Kaelin, W. G. et al. Cell 70, 351–364 (1992).
Zamanian, M. & La Thangue, N. B. EMBO J. 11, 2603–2610 (1992).
Baker, S. J., Morkowitz, S., Fearon, E. R., Willson, J. K. & Vogelstein, B. Science 249, 912–915 (1990).
Kern, S. E. et al. Science 256, 827–830 (1992).
Helin, K. et al. Cell 70, 337–350 (1992).
Liu, X., Miller, C. W., Koeffler, P. H. & Berk, A. J. Molec. cell. Biol. 13, 3291–3300 (1993).
Barak, Y., Gottlieb, E., Juren-Gerhon, T. & Oren, M. Genes Dev. 8, 1739–1749 (1994).
Bandara, L. R. et al. EMBO J. 13, 3104–3114 (1994).
Lillie, J. W. & Green, M. R. Nature 338, 39–44 (1989).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Martin, K., Trouche, D., Hagemeier, C. et al. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375, 691–694 (1995). https://doi.org/10.1038/375691a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/375691a0
- Springer Nature Limited
This article is cited by
-
Sempervirine inhibits RNA polymerase I transcription independently from p53 in tumor cells
Cell Death Discovery (2020)
-
Brain-Derived Neurotrophic Factor (BDNF) As a Regulator of Apoptosis under Conditions of Focal Experimental Stroke
Bulletin of Experimental Biology and Medicine (2020)
-
Selective deletion of hepatocyte platelet-derived growth factor receptor α and development of liver fibrosis in mice
Cell Communication and Signaling (2018)
-
Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment
BMC Cancer (2016)
-
Neuroblastoma: oncogenic mechanisms and therapeutic exploitation of necroptosis
Cell Death & Disease (2015)